ArticleOncoTargets and therapy2021

Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer.

Guannan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.